Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams A. Metabolomics: small-molecule ’omics. The Scientist, 17: 38 (2003).
Amer RK, Pace-Asciak CR, Mills LR. A lipoxygenase product, hepoxilin A(3), enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro. Neuroscience, 116: 935–946 (2003).
Bannenberg GL et al. Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J. Exp. Med., 199: 515–523 (2004).
Bender F et al. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res., 35: 151–167 (2002).
Berger A et al. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis., 1: 2 (2002a).
Berger A et al. Unraveling lipid metabolism with microarrays: effects of arachidonate and docosahexaenoate acid on murine hepatic and hippocampal gene expression. Genome Biol 3: PREPRINT0004, May (2002b)
Berger A, Roberts MA. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic gene expression. In Berger A and Roberts MA (eds), Unraveling lipid metabolism with microarrays and other “omic” approaches, Marcel Dekker, NY, 2004.
Boeglin WE, Kim RB, Brash AR. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. USA, 95: 6744–6749 (1998).
Boucher A et al. Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J. Biol. Chem., 279: 27263–27271 (2004).
Bowcock AM et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet., 10: 1793–1805 (2001).
Bowers R et al. Oxidative stress in severe pulmonary hypertension. Am. J. Respir. Crit. Care Med., 169: 764–769 (2004).
Brindle JT et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med., 8: 1439–1445 (2002).
Burstein SH et al. Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem. Pharmacol., 64: 1147–1150 (2002).
Capdevila JH, Nakagawa K, Holla V. The CYP P450 arachidonate monooxygenases: enzymatic relays for the control of kidney function and blood pressure. Adv. Exp. Med. Biol., 525: 39–46 (2003).
Cheng H, Han X. The effects of ApoE on the lipidome of mouse peripheral nervous system: A two-dimensional electrospray ionization mass spectrometric study. Abstract 193, ASMS 2004 Meeting, Nashville, TN, May 23–27, (2004).
Chu CJ et al. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem., 278: 13633–13639 (2003).
Coen M et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol., 16: 295–303 (2003).
Coen M et al. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J. Pharm. Biomed. Anal., 35: 93–105 (2004).
Colarow L et al. Characterization and biological activity of gangliosides in buffalo milk. Biochim. Biophys. Acta, 1631: 94–106 (2003).
Cowart LA et al. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J. Biol. Chem., 277: 35105–35112 (2002).
Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res., 44: 233–242 (2003).
Deighton N et al. A metabolomics study of Plasmodium falciparum infection of red blood cells in the absence and presence of antimalarials. Abstract 257, ASMS 2004 Meeting, May 23–27, (2004).
Di Gennaro A et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J., 18: 842–844 (2004).
Dufour F et al. Abnormal cholesterol processing in Alzheimer’s disease patients fibroblasts. Neurobiol. Lipids, 1: 34–45 (2003).
Ejsing CS et al. Shotgun Lipidomics: high throughput profiling of the molecular composition of phospholipids. Oral presentation, ASMS 2004 Meeting, Nashville, TN, May 23–27, (2004).
Fiehn O. Metabolomics—the link between genotypes and phenotypes. Plant Mol. Biol., 48: 155–171 (2002).
Fisher-Wilson J. Long-suffering lipids gain respect: Technical advances and enhanced understanding of lipid biology fuel a trend toward lipidomics. The Scientist, 17: 5 (2003).
Forrester JS et al. Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol., 65: 813–821 (2004).
Foster LJ, De Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. USA, 100: 5813–5818 (2003).
Gascard P et al. Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane. Biochim. Biophys. Acta, 1069: 27–36 (1991).
Godin JP et al. [2H/H] Isotope ratio analyses of [2H5]cholesterol using high-temperature conversion elemental analyser isotope-ratio mass spectrometry: determination of cholesterol absorption in normocholesterolemic volunteers. Rapid Commun. Mass Spectrom., 18: 325–330 (2004).
Gremaud G et al. Simultaneous assessment of cholesterol absorption and synthesis in humans using on-line gas chromatography/ combustion and gas chromatography/pyrolysis/isotoperatio mass spectrometry. Rapid Commun. Mass Spectrom., 15: 1207–1213 (2001).
Griffiths WJ. Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids. Mass Spectrom. Rev., 22: 81–152 (2003).
Gronert K et al. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J. Immunol., 172: 1856–1861 (2004).
Ham BM et al. Identification, quantification and comparison of major nonpolar lipids in normal and dry eye tears by ES-MS/MS. Oral presentation, ASMS 2004 Meeting, Nashville, TN, May 23–27, (2004).
Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J. Lipid Res., 44: 1071–1079 (2003).
Hanash S. Disease proteomics. Nature, 422: 226–232 (2003).
He F. Measuring metabolic responses of hepatocytes to drug treatment using FTMS. Presented at Cambridge Healthtech Institute’s 2nd Annual Metabolic Profiling: Pathways in Discovery, Durham, North Carolina, Dec 2–3, 2002, (2002).
Hong MY et al. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis, 23: 1919–1925 (2002).
Hong S et al. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem., 278: 14677–14687 (2003).
Huang SM et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci USA, 99: 8400–8405 (2002).
Hughey CA, Rodgers RP, Marshall AG. Resolution of 11,000 compositionally distinct components in a single electrospray ionization Fourier transform ion cyclotron resonance mass spectrum of crude oil. Anal. Chem., 74: 4145–4149 (2002).
Ivanova PT et al. LIPID Arrays: New tools in the understanding of membrane dynamics and lipid signaling. Mol. Interv., 4: 86–96 (2004).
Johnson DW. Deuterium labeled dicarboxylic acylcarnitines for the differentiation of fatty acid oxidation disorders by tandem mass spectrometry. Abstract 44, ASMS 2004 Meeting, Nashville, TN, May 23–27, (2004).
Kaddurah-Daouk R et al. Bioanalytical advances for metabolomics and metabolic profiling. PharmaGenomics, Jan: 46–52 (2004).
Lindon JC et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol., 187: 137–146 (2003).
Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat. Biotechnol., 21: 255–261 (2003).
Mims D, Hercules D. Quantification of bile acids directly from urine by MALDI-TOF-MS. Anal. Bioanal. Chem., 375: 609–616 (2003).
Mortishire-Smith RJ et al. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem. Res. Toxicol., 17: 165–173 (2004).
Mutch DM et al. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. FASEB J. (In press).
Parton RG. Caveolae—from ultrastructure to molecular mechanisms. Nat. Rev. Mol. Cell. Biol., 4: 162–167 (2003).
Perwaiz S et al. Rapid and improved method for the determination of bile acids in human feces using MS. Lipids, 37: 1093–1100 (2002).
Pettus BJ et al. Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry. Rapid Commun. Mass Spectrom., 18: 577–583 (2004).
Phelps TJ, Palumbo AV, Beliaev AS. Metabolomics and microarrays for improved understanding of phenotypic characteristics controlled by both genomics and environmental constraints. Curr. Opin. Biotechnol., 13: 20–24 (2002).
Pike LJ et al. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry (Mosc), 41: 2075–2088 (2002).
Pouteau E et al. Determination of cholesterol absorption in humans: from radiolabel to stable isotope studies. Isotopes Environ. Health Stud., 39: 247–257 (2003a).
Pouteau EB et al. Non-esterified plant sterols solubilized in low fat milks inhibit cholesterol absorption—a stable isotope double-blind crossover study. Eur. J. Nutr., 42: 154–164 (2003b).
Pulfer MK, Murphy RC. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J. Biol. Chem., 279: 26331–26338 (2004).
Richelle M et al. Both free and esterified plant sterols decrease cholesterol absorption and the bioavailability of βcarotene and α-tocopherol, in normocholesterolemic humans. Am. J. Clin. Nutr., 80: 171–177 (2004).
Schnitzer JE. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo,. Adv. Drug Deliv. Rev., 49: 265–280 (2001).
Serhan CN. Clues for new therapeutics in osteoporosis. N. Engl. J. Med., 350: 1902–1903 (2004).
Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat., 68–69: 433–455 (2002).
Serhan CN, Chiang N. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics. Rheum. Dis. Clin. North Am., 30: 69–95 (2004).
Serhan CN et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med., 196: 1025–1037 (2002).
Sommerer D et al. Analysis of the phospholipid composition of bronchoalveolar lavage (BAL) fluid from man and minipig by MALDI-TOF mass spectrometry in combination with TLC. J. Pharm. Biomed. Anal., 35: 199–206 (2004).
Sullards MC et al. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. Cell. Mol. Biol,. 49: 789–797 (2003).
Sumner SCJ, Liu G. Metabolomics holds key to intelligent discovery efforts. Genetic Engineering News, 22: 32–33 (2002).
Varnau M, Singhania A. Dynamic metabolomics industry emerges. Genetic Engineering News, 22: 15–17; 93 (2002).
Walker JM, Huang SM. Endocannabinoids in pain modulation. Prostaglandins Leukot Essent Fatty Acids, 66: 235–242 (2002).
Watkins SM. Lipomic profiling in drug discovery, development and clinical trial evaluation. Curr. Opin. Drug Discov. Devel., 7: 112–117 (2004).
Watkins SM, German JB. Metabolomics and biochemical profiling in drug discovery and development. Curr. Opin. Mol. Ther., 4: 224–228 (2002).
Weckwerth W, Fiehn O. Can we discover novel pathways using metabolomic analysis? Curr. Opin. Biotechnol., 13: 156–160 (2002).
Weckwerth W, Wenzel K, Fiehn O. Process for the integrated extraction, identification and quantification of metabolites, proteins and RNA to reveal their coregulation in biochemical networks. Proteomics, 4: 78–83 (2004).
Welti R, Wang X. Lipidomics. Inform., 14: 607–608 (2003).
Wen Z, Kim H-Y. Alterations in hippocampal phospholipid profile by prenatal exposure to ethanol. J. Neurochem., 89: 1368–1377 (2004).
Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer, 3: 267–275 (2003).
Yang W. Lipomics: mastering metabolites. Biocentury, The Bernstein report on BioBusiness A13 (2003).
Zarini S, Murphy RC. Biosynthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid from 5-hydroperoxyeicosatetraenoic acid in the murine macrophage. J. Biol. Chem., 278: 11190–11196 (2003).
Ziboh VA et al. Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin. Arch. Pharm. Res., 25: 747–758 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Berger, A. (2005). How Lipidomic Approaches Will Benefit the Pharmaceutical Industry. In: Vaidyanathan, S., Harrigan, G.G., Goodacre, R. (eds) Metabolome Analyses: Strategies for Systems Biology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25240-1_20
Download citation
DOI: https://doi.org/10.1007/0-387-25240-1_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25239-1
Online ISBN: 978-0-387-25240-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)